publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
studi
transmiss
effici
conduct
prevent
trial
dorak
particip
data
analysi
interpret
result
prepar
manuscript
j
tang
e
lobashevski
respons
hla
type
laboratori
data
acquisit
manag
contribut
analysi
prepar
manuscript
penmanaguilar
westfal
schaen
respons
statist
analysi
manag
full
dataset
review
final
version
manuscript
zulu
n
g
kancheya
assist
protocol
develop
assembl
particip
supervis
onsit
collect
epidemiolog
data
biolog
specimen
review
latest
version
manuscript
allen
r
kaslow
design
origin
studi
framework
immunogenet
analys
supervis
collect
relev
clinic
epidemiolog
data
biolog
specimen
data
analysi
interpret
review
success
draft
manuscript
sar
coronaviru
continu
caus
sporad
case
sever
acut
respiratori
syndrom
sar
china
activ
passiv
immunoprophylaxi
diseas
induc
sar
coronaviru
avail
investig
prophylaxi
sar
coronaviru
infect
neutralis
human
monoclon
antibodi
ferret
readili
infect
viru
prophylact
administr
monoclon
antibodi
mgkg
reduc
replic
sar
coronaviru
lung
infect
ferret
log
ci
log
p
complet
prevent
develop
sar
coronavirusinduc
macroscop
lung
patholog
abolish
shed
viru
pharyng
secret
data
gener
anim
model
show
administr
human
monoclon
antibodi
might
offer
feasibl
effect
prophylaxi
control
human
sar
coronaviru
infect
incub
h
differ
concentr
control
antibodi
presenc
absenc
cytopath
effect
score
well
day
infect
percentag
protect
well
note
figur
test
invivo
potenc
antibodi
ferret
anim
readili
infect
sar
coronaviru
intratrach
rout
replic
viru
high
titr
lung
develop
macroscop
microscop
lung
lesion
experiment
infect
ferret
human
respiratori
virus
includ
influenza
virus
common
practic
therefor
procedur
work
anim
biocontain
condit
requir
sar
coronaviru
well
establish
approv
anim
experi
obtain
institut
anim
welfar
committe
first
set
experi
ferret
mustela
furo
femal
weight
g
infect
intratrach
either
tcid
tcid
group
sar
coronaviru
strain
preincub
ml
cellcultur
medium
h
either
human
control
monoclon
antibodi
group
concentr
antibodi
medium
excess
concentr
theoret
need
neutralis
challeng
dose
mgml
lower
mgml
higher
challeng
dose
pharyng
swab
taken
anim
challeng
day
challeng
frozen
subject
quantit
rtpcr
two
anim
four
group
kill
day
necropsi
done
accord
standard
protocol
assess
lung
inflamm
associ
sar
coronaviru
infect
haematoxylineosinstain
section
cranial
caudal
part
lung
examin
inflammatori
foci
light
microscopi
object
measur
sar
coronaviru
titr
homogen
prepar
g
lung
tissu
pool
cranial
medial
caudal
part
lung
control
ferret
high
titr
sar
coronaviru
lung
day
lower
titr
day
viral
replic
accompani
multifoc
pulmonari
lesion
affect
surfac
area
lung
histolog
lesion
consist
mainli
mild
alveolar
damag
well
peribronchi
perivascular
lymphocyt
infiltr
rtpcr
pharyng
swab
show
viru
shed
throat
throughout
day
anim
expos
mixtur
viru
almost
undetect
titr
sar
coronaviru
lung
show
lung
lesion
day
shed
sar
coronaviru
throat
second
set
experi
two
group
ferret
group
receiv
intraperiton
inject
either
control
antibodi
concentr
mgkg
h
intratrach
infect
tcid
sar
coronaviru
strain
venou
blood
drawn
administr
monoclon
antibodi
challeng
day
challeng
measur
human
content
serum
elisa
neutralis
capac
neutralis
assay
use
fix
virusvari
serumdilut
format
pharyng
swab
taken
anim
inocul
day
challeng
quantit
rtpcr
anim
kill
day
lung
sampl
taken
describ
first
set
experi
mean
sar
coronaviru
titr
lung
homogen
anim
given
log
lower
anim
reservoir
two
recent
case
laboratoryacquir
sar
coronaviru
infect
china
spread
commun
trigger
extens
effort
trace
isol
contact
patient
prevent
new
epidem
mean
control
sar
coronaviru
infect
activ
passiv
immunis
therefor
urgent
need
passiv
transfer
mous
immun
serum
shown
reduc
pulmonari
viral
titr
mice
infect
sar
coronaviru
immunoprophylaxi
sar
coronaviru
infect
human
monoclon
antibodi
might
therefor
viabl
strategi
control
sar
gener
human
monoclon
antibodi
reactiv
whole
inactiv
sar
coronaviru
antibodi
phage
display
technolog
screen
larg
naiv
antibodi
librari
bind
antibodi
viral
peplom
visualis
electron
microscopi
indirect
twostep
immunogold
label
sar
coronaviru
supernat
infect
vero
cell
adsorb
copper
grid
coat
carbon
pioloform
incub
monoclon
antibodi
float
droplet
min
room
temperatur
bound
monoclon
antibodi
detect
incub
droplet
nm
conjug
british
biocel
cardiff
uk
grid
neg
contrast
uranyl
acet
assess
zeiss
em
transmiss
electron
microscop
figur
shown
react
cellsurfac
express
spike
glycoprotein
sar
coronaviru
cell
transfect
plasmidexpress
codonoptimis
fulllength
glycoprotein
spike
stain
rphycoerythrinlabel
second
antibodi
h
use
standard
procedur
facsanalysi
figur
also
shown
neutralis
sar
coronaviru
vitro
triplic
well
vero
cell
infect
tcid
tissu
cultur
infect
dose
sar
coronaviru
strain
pre
figur
reduct
microscop
lesion
compar
control
show
multifoc
lesion
gross
necropsi
figur
shed
sar
coronaviru
throat
complet
abolish
three
four
anim
treat
figur
howev
one
anim
level
sar
coronaviru
excret
similar
note
control
group
concentr
serum
ferret
challeng
less
gml
compar
gml
three
anim
suggest
inappropri
antibodi
administr
neutralis
serum
titr
anim
less
half
anim
day
titr
tcid
detect
day
infect
compar
titr
tcid
anim
day
sar
coronaviru
detect
nasopharyng
aspir
sar
patient
associ
increas
mortal
lung
autopsi
patient
viral
isol
rtpcr
basi
data
success
prophylaxi
respiratori
syncyti
viru
diseas
humanis
monoclon
antibodi
palivizumab
reason
immunoprophylaxi
sar
coronaviru
infect
human
monoclon
antibodi
might
option
control
sar
prophylact
dose
use
mgkg
less
mgkg
dose
palivizumab
given
intramuscularli
atrisk
infant
month
reduc
replic
sar
coronaviru
peopl
extent
ferret
view
serum
halflif
day
human
be
one
intramuscular
administr
dose
use
studi
protect
adult
length
least
one
two
sar
coronaviru
incub
period
median
day
passiv
immunis
might
therefor
feasibl
approach
prevent
lung
manifest
peopl
expos
sar
coronaviru
prevent
persontoperson
spread
viru
abolish
viral
shed
pharyng
secret
j
ter
meulen
b
h
bakker
g
j
weverl
j
goudsmit
e
osterhau
plan
studi
analys
data
wrote
report
e
n
van
den
brink
j
de
kruif
w
preiser
w
spaan
gener
characteris
recombin
antibodi
h
r
gelderblom
electron
microscopi
b
e
e
martina
b
l
haagman
anim
experi
viru
titrat
kuiken
patholog
analysi
author
saw
approv
final
version
manuscript
